Tamoxifen: disease prevention or disease substitution?
- 7 November 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 340 (8828) , 1143-1145
- https://doi.org/10.1016/0140-6736(92)93161-f
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Overview From the International Conference on Long-Term Tamoxifen Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Contralateral Primary Tumors in Breast Cancer Patients in a Randomized Trial of Adjuvant Tamoxifen TherapyJNCI Journal of the National Cancer Institute, 1991
- Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.Journal of Clinical Oncology, 1990
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Bone mineral content of women receiving tamoxifen for mastalgiaBritish Journal of Cancer, 1989
- A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerBritish Journal of Cancer, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsBreast Cancer Research and Treatment, 1988
- The effect of tamoxifen on bone mineral content in premenopausal women with breast cancerCancer, 1984